Prostate cancer development and progression have been heavily linked to Androgen Receptor (AR) signalling pathway; thus, androgen deprivation therapy (ADT) has been used for patients who have advanced prostate cancer (Hatano & Nonomura, 2021). Here, AR is linked to prostate carcinoma.